Triton Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $36.3M

  • Investors
  • 3

Triton Therapeutics General Information

Description

Developer of therapeutic compounds intended to address autoimmune and fibrotic medical conditions. The company platform engages in the clinical-stage research and development of novel medical agents that precisely target the underlying disease pathways, enabling patients with complex chronic diseases to access treatment options with the potential to significantly modify the disease course and improve long-term health outcomes.

Contact Information

Website
www.tritonthera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 700 Fairfield Avenue
  • Suite 1
  • Stamford, CT 06902
  • United States
+1 (203)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 700 Fairfield Avenue
  • Suite 1
  • Stamford, CT 06902
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Triton Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 23-Oct-2025 $36.3M Completed Clinical Trials - General
1. Accelerator/Incubator Completed Clinical Trials - General
To view Triton Therapeutics’s complete valuation and funding history, request access »

Triton Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
To view Triton Therapeutics’s complete cap table history, request access »

Triton Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Canaan Partners Venture Capital Minority
Cure Ventures Venture Capital Minority
Yale Ventures Accelerator/Incubator
To view Triton Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Triton Therapeutics FAQs

  • When was Triton Therapeutics founded?

    Triton Therapeutics was founded in 2025.

  • Where is Triton Therapeutics headquartered?

    Triton Therapeutics is headquartered in Stamford, CT.

  • What industry is Triton Therapeutics in?

    Triton Therapeutics’s primary industry is Drug Discovery.

  • Is Triton Therapeutics a private or public company?

    Triton Therapeutics is a Private company.

  • What is the current valuation of Triton Therapeutics?

    The current valuation of Triton Therapeutics is .

  • What is Triton Therapeutics’s current revenue?

    The current revenue for Triton Therapeutics is .

  • How much funding has Triton Therapeutics raised over time?

    Triton Therapeutics has raised $36.3M.

  • Who are Triton Therapeutics’s investors?

    Canaan Partners, Cure Ventures, and Yale Ventures have invested in Triton Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process